NATA - Nucleic Acid Therapy Accelerator
Shalini Andersson

Shalini Andersson

Chief Scientist Of New Therapeutic Modalities And Head Of Oligonucleotide Discovery, Astrazeneca (sweden) at NATA - Nucleic Acid Therapy Accelerator

Org chart

View in org chart

Manager

Nick Lench

Executive Director

Peers

Laura Sepp - Lorenzino

Chief Scientific Officer, Intellia Therapeutics (us)

Anne Willis

Professor Of Toxicology And MRC Toxicology Unit Director, University Of Cambridge (uk)

Alison Smith

Vice President, Portfolio And Technology Delivery, GSK

View in org chart

Timeline

Chief Scientist Of New Therapeutic Modalities And Head Of Oligonucleotide Discovery, Astrazeneca (sweden)
Current role